Mutations in FAT1 have been described in various cancers, including leukemias and hepatocellular carcinoma, and altered, predominantly reduced, expression of FAT1 protein has been reported in these and other cancers, the latter including head and neck, esophageal, cervical, and breast carcinoma [reviewed in 17]. This evidence concerns the gene FAT1 and hepatocellular carcinoma.